Test Code 8722TI

Test Name Methadone and Metabolite, Tissue

Purpose
Identification and Quantitation
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80358
New York State Approval Status

Approved

Turnaround Time

4 days

Test Includes
1 Methadone Dolophine® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 20 Narcotic Analgesic
2 EDDP Methadone Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 20 Narcotic Analgesic

Test Also Known As
Methadose®
Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Specimen Type
Tissue
Requested Volume
10 g
Minimum Volume
10 g
Special Handling
None
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
None

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined
1 Methadone Dolophine® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 20 Narcotic Analgesic
2 EDDP Methadone Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/g 20 Narcotic Analgesic

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.